ID: ALA5283850

Max Phase: Preclinical

Molecular Formula: C11H8N4OS2

Molecular Weight: 276.35

Associated Items:

Representations

Canonical SMILES:  Cc1nc2ccccc2c(=O)n1-c1nnc(S)s1

Standard InChI:  InChI=1S/C11H8N4OS2/c1-6-12-8-5-3-2-4-7(8)9(16)15(6)10-13-14-11(17)18-10/h2-5H,1H3,(H,14,17)

Standard InChI Key:  VLCJTAGXWCJKPC-UHFFFAOYSA-N

Associated Targets(non-human)

Ehrlich 1318 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 276.35Molecular Weight (Monoisotopic): 276.0140AlogP: 1.83#Rotatable Bonds: 1
Polar Surface Area: 60.67Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.56CX Basic pKa: 0.21CX LogP: 1.89CX LogD: 1.09
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.69Np Likeness Score: -1.68

References

1. Plescia F, Maggio B, Daidone G, Raffa D..  (2021)  4-(3H)-quinazolinones N-3 substituted with a five membered heterocycle: A promising scaffold towards bioactive molecules.,  213  [PMID:33309162] [10.1016/j.ejmech.2020.113070]

Source